Cargando…
A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression
Chronic tissue injury with fibrosis results in the disruption of tissue architecture, organ dysfunction, and eventual organ failure. Therefore, the development of effective antifibrotic drugs is urgently required. IMB-S7 is novel biphenyl compound derived from bifendate (biphenyldicarboxylate) that...
Autores principales: | Zhang, Na, Zhao, Shuang-shuang, Zhang, Yi-xuan, Wang, Yu-cheng, Shao, Rong-guang, Wang, Ju-xian, He, Hong-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470799/ https://www.ncbi.nlm.nih.gov/pubmed/31932644 http://dx.doi.org/10.1038/s41401-019-0325-6 |
Ejemplares similares
-
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
por: Hu, Liangshuo, et al.
Publicado: (2019) -
Neutrino measurements with the IMB detector
por: Becker-Szendy, R A, et al.
Publicado: (1994) -
Alimentations de correction des enroulements BDL, QCD et QCF
por: Métais, Μ
Publicado: (1981) -
AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats
por: Zhu, Haoyang, et al.
Publicado: (2018) -
Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro
por: Niu, Xia, et al.
Publicado: (2021)